You are in: eMedicine Specialties > Ophthalmology > REFRACTIVE DISORDERS Hyperopia, LASIKArticle Last Updated: Apr 4, 2006AUTHOR AND EDITOR INFORMATIONSection 1 of 11
  Author: Arun Gulani, MD, Director, Gulani Vision Institute Arun Gulani is a member of the following medical societies: American Academy of Ophthalmology Editors: Daniel S Durrie, MD, Director, Department of Ophthalmology, Division of Refractive Surgery, University of Kansas Medical Center; Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles; Louis E Probst, MD, Medical Director of Refractive Surgery, Chicago, Madison, Milwaukee, and Windsor Centers, TLC the Laser Eye Centers; Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri; Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences Author and Editor Disclosure Synonyms and related keywords: hyperopic LASIK, farsightedness, laser refractive surgery, distance vision, excimer laser, laser in situ keratomileusis INTRODUCTIONSection 2 of 11
  The surgical reduction of hyperopia is an evasive but worthy pursuit since hyperopia affects both distance and near vision and is compounded by presbyopia at a time when patients are in the prime of their vocational and personal life. A wide spectrum of refractive surgeries has been applied over the years in the relentless pursuit of hyperopia correction. With the introduction of the excimer laser, the possibilities of carving a positive lenticule into the cornea were investigated. To steepen an untreated corneal center, it is necessary to have a relatively deep peripheral ablation with a progressive steepening of the transition of zone 1. The argon fluoride 193-nm excimer laser corrects refractive errors by sub–micron-precision tissue removal from the cornea. Photorefractive keratectomy (PRK) has been used successfully for hyperopia but has problems of regression, induced astigmatism, and corneal haze, thereby limiting its usefulness to the correction of mild hyperopia only. Excimer laser in situ keratomileusis (LASIK) overcomes many disadvantages of surface ablation (PRK) and has become the procedure of choice for treating hyperopia up to +6.00 diopters (D). History of the ProcedureThe technique routinely used for hyperopic LASIK uses a 160- to 180-µm thick corneal flap and a wide ablation with a peripheral blend zone. With different output systems and configurations unique to each excimer laser system, the conceptual ablation pattern results in a relative central steepening to correct the hyperopia. When using a broad beam laser, the central cornea could be protected from the laser ablation, while the periphery would ablate resulting in central steepening. The author had been practicing this technique to correct low hyperopia with good results but was finding patient fixation and surgeon control to be an obstinate problem. Surgical innovation in hyperopic LASIK - Design of masks Three acrylate polymer masks of diameters 4.5 mm, 4 mm, and 3.5 mm, respectively, were designed and custom made by Gulani (see Image 1). The surface of the masks was spherical, convex for hyperopia correction. The edges were thinned out evenly to a smoothly polished finish. These masks were centered on the exposed corneal stroma between the laser beam and the eye, successively starting with the 4.5-mm mask, followed by the 4-mm mask, and, finally, the 3.5-mm mask, to allow the final ablation pattern to reveal a central graduated steepening comprised of 3 concentric rings. The lenses were transparent with a green tint to allow for maximum light penetration by the green fixation light on the laser. Each lens was +2.5 D in power to aid fixation by the hyperopic patient. A specially designed triple zone marker and lens placement forceps (designed by Gulani) were used with these lenses during surgery. The principle behind designing these lenses stemmed from a desire to improve patient fixation and surgeon visibility of the ongoing procedure. Prior to the use of these masks, aluminum masks of the same base diameters, respectively, were used. Since these masks were not transparent, the patients could not see the fixation light and had a tendency to wander unless closely held by the globe fixator (designed by Gulani). Also, the surgeon could not see the corneal stroma under these masks; therefore, they had no active role to play in centration of the final concentric ring ablation pattern. Making these lenses out of a transparent material helped both the surgeon and the patient and resulted in a well-controlled, supervised, and predictable hyperopic laser corneal sculpting (see Image 2). Now, the surgeon could center these lenses and maintain direct observation during laser ablation. These lenses were modified further to incorporate a green tint, with each powered to +2.5 D. These factors further enhanced patient fixation and centration in the following ways:
All of the above features helped to improve patient fixation and to decrease anxiety, enabling a well-centered hyperopic corneal sculpting with consistent results. ProblemHyperopia generally is due to a shorter axial length or reduced corneal dioptric strength. FrequencyVarious figures are given, but, generally, it is believed that hyperopia affects millions of individuals in the United States. EtiologyHyperopia may run in families. ClinicalA primary finding is a reduction of vision. Near or distance vision can be affected depending on age and refractive error. With proper correction, the vision is good. INDICATIONSSection 3 of 11
In this study, LASIK was used to treat 4 different groups of hyperopia, as follows:
This article is limited to discussion of LASIK for virgin eyes with hyperopia less than 6.00 D and coexisting astigmatism of less than 0.75 D and the impact of the new intra-ablative lenses on the same eyes. RELEVANT ANATOMYSection 4 of 11
With hyperopia, the axial length is generally shorter or the corneal dioptric strength is weaker. CONTRAINDICATIONSSection 5 of 11
Contraindications for LASIK include lupus erythematous and rheumatoid arthritis. TREATMENTSection 6 of 11
Preoperative detailsThis study included the first consecutive 49 eyes with preoperative hyperopia ranging from +1.25 D to +6.25 D with less than 0.75 D astigmatism and followed for 6 months postoperatively. A Lambda Physik 193-nm argon fluoride excimer laser at a fluence of 130 mJ/cm² was used for these cases. Every patient underwent protocol preoperative ophthalmic tests that included a thorough slit lamp biomicroscopy, manual keratometry and autokeratometry, corneal topography, corneal pachymetry, specular microscopy, cycloplegic refraction, and recorded uncorrected and best-corrected visual acuity. Intraoperative detailsAll eyes were operated on under topical anesthesia. The corneal flap was created using the Chiron automated corneal shaper after making an epithelial mark with the Gulani LASIK marker and checking the intraocular pressure with the Barraquer tonometer. The flap was deliberately decentered nasally. The flap was gently lifted and reflected on itself nasally. With the patient fixating at the fixation light, the Gulani triple lens marker was used to mark the anterior stroma with 3 concentric rings of 4.5-, 4-, and 3.5-mm diameters, respectively. Using a specially designed cupped lens forceps, the 4.5-mm lens was placed onto the stomal bed on the 4.5-mm mark and gently tapped into place (see Image 3). The flap hinge protector was used to prevent inadvertent ablation of the corneal flap hinge. In some cases, the globe stabilizer was used for apprehensive patients with excessive eye movements despite good visibility of the fixation light. The pretested and calibrated laser performed nomogram-directed ablation with a beam diameter of 7 mm. A suction nozzle was held close to the eye by an assistant during ablation to address the plume and other unwanted products of the laser-corneal interaction. Following this first stage of hyperopic laser ablation, the 4.5-mm lens was lifted off the cornea and replaced by a 4-mm lens, which was then centered within the ablation edge of the previous laser-corneal interaction. Ablation is continued, followed by the final stage using the 3.5-mm lens. After completing the hyperopic ablation using these 3 lenses successively, the surgeon can appreciate the concentric ring pattern of 3 rings with smooth edges under high magnification (see Images 4-5). The stromal bed is now irrigated with balanced salt solution using the Gulani triple function LASIK cannula, while the corneal flap is floated back into position in alignment with the previously placed epithelial marks. Then, the flap is squeegeed gently using the bulbous tip of the cannula and air dried at the edges for 1 minute. The flap adherence is tested by applying the striae test, and, after speculum removal, it is tested by the blink test. Postoperative detailsDry eye is common after LASIK, and over-the-counter preservative-free lubricants are important. Follow-upPatients usually are seen the day after surgery, 2 weeks after surgery, and then as needed. For excellent patient education resources, visit eMedicine's Eye and Vision Center. Also, see eMedicine's patient education article Vision Correction Surgery. COMPLICATIONSSection 7 of 11
Complications include displaced flap, corneal perforation, interface debris, and diffuse lamellar keratitis. OUTCOME AND PROGNOSISSection 8 of 11
The results of hyperopic LASIK have been encouraging and relatively stable at 6 months postoperatively. Refractive stability occurred from 1-2 weeks postoperatively and remained stable at 6 months. The results with uncorrected visual acuity were similar, with vision stabilizing from 1-2 weeks postoperative. In this study, LASIK patients had a mean preoperative sphere of +2.6 D. Ninety percent of the eyes attained 20/40 or better postoperative unaided vision, while 50% of eyes were 20/20. These results correlated with a hyperopic LASIK report of a similar preoperative hyperopic category of patients in which 95% of eyes achieved 20/40 or better unaided vision. No lines of best-corrected visual acuity were lost. In this study series, no significant haze, decentrations, central islands, irregular astigmatism, or interface deposits/inflammation were observed. Epithelial ingrowth did occur in 3 cases. This epithelial ingrowth was mild and restricted to the periphery. In these cases, the corneal flaps were uniform in thickness and well aligned as were the corneal topographies. At the 8-month postoperative gate, one of these eyes underwent flap lifting and interface cleansing. A specially designed flap lifter was used to elevate the flap without eroding the surgically steepened stromal mound. FUTURE AND CONTROVERSIESSection 9 of 11
The surgical correction of hyperopia remains a challenge and a worthy pursuit in the field of refractive surgery. The basic principle of corneal surgery for hyperopic correction remains in carving a lens shape that is steeper in the center by graded removal of tissue in the periphery. The possibility of regression will continue to be a concern in such a surgical profile because of the natural or sometimes hyperplastic healing response of the cornea to fill in this ablated step between the treated and untreated zones, thereby not only resulting in loss of effect over time but also inducing an astigmatic error in case of uneven fill-ins. With the surge of technological advances and the availability of smoother ablation systems, along with microkeratomes aiding larger corneal flaps, these concerns may be addressed. This author has no experience with piggyback intraocular lenses. In the author's experience, LASIK is presently the treatment of choice for this grade of hyperopia. A welcome surprise in the results was a simultaneous improvement in near vision associated with this hyperopic LASIK technique. An investigation occurred to check if cylinder was being induced, thereby aiding the patient's presbyopia; the investigation revealed no significant induction of cylinder. Therefore, this improvement in presbyopia could be a direct result of the corneal multifocality that results from this work. Such postablation corneal multifocality has been previously observed and reported. This improvement is a welcome advantage in the presbyopic age group and has remained stable at the 6-month postoperative gate. Hyperopic LASIK using these intra-ablative contact lenses has been successful at the 6-month postoperative period with no loss of best-corrected visual acuity. The future of refractive surgery seems promising as a transition is predicted from cornea-focused refractive surgery with its inherent variabilities toward the more predictable and focused phakic implants. At this time, the important issue is that hyperopia is finally receiving its due attention. MULTIMEDIASection 10 of 11
REFERENCESSection 11 of 11
Article Last Updated: Apr 4, 2006 | ||||||||||||||||||||||||||||||||||||||||||
